Esta nueva convocatoria ha tenido como finalidad la financiación de un proyecto de investigación traslacional de medicina personalizada (identificación de nuevos biomarcadores diagnósticos y pronÃ...
Read moreDos terapias CAR-T dirigidas a dos proteÃnas asociadas a tumores consiguen reducir el crecimiento tumoral en pacientes con glioblastoma.
Read moreCertain variations in our DNA, which had previously gone unnoticed, can have a significant impact on the development of cancer.
Read moreMedibiofarma, empresa biofarmacéutica navarra que se dedica a descubrir y desarrollar nuevas terapias para enfermedades de alta necesidad médica, ha cerrado una ronda de financiación por valor de u...
Read moreEste estudio crea las bases de una medicina completamente personalizada centrando el trabajo en una área de investigación emergente conocida como radiogenómica
Read moreOryzon Genomics, S.A. announces that it has obtained the INNOVATIVE SME seal from the Spanish Ministry of Science and Innovation, and has consequently been registered in the Public Registry of INNOVAT...
Read moreResults of the multi-center iPROMET study identify whole-body magnetic resonance imaging as a biomarker of response in prostate cancer patients with bone metastases. Currently, standard approaches are...
Read moreThe main disadvantages they highlight are insufficient projection of the nipple and the disappearance of the colour over time.
Read moreOncoheroes Biosciences reveals the development of an innovative screening platform aimed at identifying potential drug candidates for medulloblastoma, a type of brain cancer prevalent in children
Read moreOryzon Genomics announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application to initiate a Phase I/II trial with iadademstat plus immune...
Read moreI has been developed micromaterials made up only of proteins, capable of delivering over an extended period of time nanoparticles that attack specific cancer cells and destroy them. The micromaterials...
Read moreA team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded through the Horizon 2020 programme, used their expertise and all they learnt in the colorectal and lung cancer scr...
Read more